Abstract
The mean age of the patients was 53.6 years, with the sample consisting of 304 (55.98%) females and 239 (44.02%) males. The first three cancer diagnoses were breast cancer (35.72%), colon cancer (31.67%), and stomach cancer (12.89%). In most patients (72.37%), the right subclavian vein was used as the intervention site. Complications occurred in 8.8% (48 patients) of the patients in the early (1.28%) or late periods (6.8%) after the procedure. Catheter-related infection was the most common complication, at 2.5%.
Highlights
Appropriate venous vascular access is critical in the long-term treatment process for patients diagnosed with cancer and receiving chemotherapy
Some complications may occur during the insertion and use of totally implantable venous port catheters, they are convenient for use in the treatment of patients undergoing chemotherapy
This study evaluated the complications associated with Totally implantable venous port catheters (TIVPCs) procedures applied to chemotherapy in oncology patients in our clinic
Summary
Appropriate venous vascular access is critical in the long-term treatment process for patients diagnosed with cancer and receiving chemotherapy. Implantable venous port catheters (TIVPCs) are vital for easier and safer treatment delivery in these patients. These catheters, first described by Broviac and Hickman in 1973, came into use in the 1980s [1,2,3]. The system consists of a silicone reservoir implanted under the skin and a catheter placed intravenously at the superior vena cava-right atrium junction. It is often placed via the subclavian vein or the jugular vein. The aim of this study was to evaluate the complications associated with totally implantable venous port catheter interventions and the management of these complications
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
